Goldman Sachs’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
221,090
+63,116
| +40% | +$343K | ﹤0.01% | 3727 |
|
|
2025
Q1 | $548K | Buy |
157,974
+51,307
| +48% | +$178K | ﹤0.01% | 4207 |
|
|
2024
Q4 | $1.1M | Buy |
106,667
+37,257
| +54% | +$383K | ﹤0.01% | 3864 |
|
|
2024
Q3 | $941K | Buy |
69,410
+33,098
| +91% | +$448K | ﹤0.01% | 3787 |
|
|
2024
Q2 | $472K | Sell |
36,312
-31,571
| -47% | -$410K | ﹤0.01% | 3988 |
|
|
2024
Q1 | $641K | Buy |
67,883
+51,661
| +318% | +$488K | ﹤0.01% | 3863 |
|
|
2023
Q4 | $178K | Buy |
+16,222
| New | +$178K | ﹤0.01% | 4363 |
|
|
2023
Q3 | – | Sell |
-16,460
| Closed | -$79.2K | – | 4939 |
|
|
2023
Q2 | $79.2K | Buy |
+16,460
| New | +$79.2K | ﹤0.01% | 4605 |
|
|
2022
Q4 | – | Sell |
-54,500
| Closed | -$1.03M | – | 5347 |
|
|
2022
Q3 | $1.03M | Buy |
+54,500
| New | +$1.03M | ﹤0.01% | 3795 |
|